The vote capped a months-long campaign to secure Califf’s confirmation after President Joe Biden nominated him to return to the post he held near the end of the Obama administration.
The Senate voted 49-45 yesterday on a cloture vote to limit debate and move toward a final vote on Califf’s confirmation.
Several Republicans joined Democrats on today’s tight vote, enabling Califf’s nomination to overcome strong opposition from Sen. Joe Manchin, D–West Virginia. Manchin has been critical of Califf’s work as a drug company consultant, suggesting that his ties to the pharma industry are too close when the country is still dealing with an opioid abuse epidemic.
Get the full story on our sister site Medical Design & Outsourcing.